Apyx Medical (APYX) Asset Writedowns and Impairment (2011 - 2026)
Apyx Medical's (APYX) quarterly Asset Writedowns and Impairment came in at $85000.0 in Q2 2026, down 40.97% on a YoY basis from $144000.0 in Q2 2025, and up 750.0% quarter-over-quarter from $10000.0 in Q1 2026.
Powered by 
Analysis
Apyx Medical (APYX) Asset Writedowns and Impairment (2011 - 2026) Analysis & Trends
Apyx Medical (APYX) has reported Asset Writedowns and Impairment for 16 consecutive years, with $85000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Asset Writedowns and Impairment fell 40.97% year-over-year to $85000.0; the trailing twelve-month figure through Jun 2026 stood at $346000.0 (down 31.89% YoY), and the FY2025 full-year result was $423000.0, up 6.82% from the prior year.
- Asset Writedowns and Impairment improved to $85000.0 in Q2 2026 per APYX's latest filing, from $10000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $294000.0 in Q4 2023 and bottomed at -$142000.0 in Q1 2023.
- Historically, Asset Writedowns and Impairment has averaged $97333.3 across 5 years, with a median of $100000.0 in 2024.
- The widest YoY moves for Asset Writedowns and Impairment: up 17500.0% in 2023, down 201.43% in 2023.
- Over 5 years, Asset Writedowns and Impairment stood at $32000.0 in 2022, then surged by 818.75% to $294000.0 in 2023, then slipped by 14.97% to $250000.0 in 2024, then sank by 45.2% to $137000.0 in 2025, then sank by 37.96% to $85000.0 in 2026.
- According to Business Quant data, Asset Writedowns and Impairment over the past three periods registered $85000.0, $10000.0, and $137000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.77 Bn | 175.17 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.65 Bn | 122.43 Bn | 1.96 Bn |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn |
| 4 | Stryker | 104.21 Bn | 100.73 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.46 Bn | 62.92 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.73 Bn | 45.48 Bn | 1.35 Bn |
| 7 | Alcon | 33.01 Bn | 31.56 Bn | 1.68 Bn |
| 8 | Dexcom | 32.17 Bn | 30.22 Bn | 830.00 Mn |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn |
| 10 | Apyx Medical | 130.67 Mn | 103.06 Mn | 8.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 85,000.00 |
| Mar 31, 2026 | 10,000.00 |
| Dec 31, 2025 | 137,000.00 |
| Sep 30, 2025 | 114,000.00 |
| Jun 30, 2025 | 144,000.00 |
| Mar 31, 2025 | 28,000.00 |
| Dec 31, 2024 | 250,000.00 |
| Sep 30, 2024 | 86,000.00 |
| Jun 30, 2024 | 53,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 294,000.00 |
| Sep 30, 2023 | 174,000.00 |
| Jun 30, 2023 | 197,000.00 |
| Mar 31, 2023 | -142,000.00 |
| Dec 31, 2022 | 32,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Jun 30, 2022 | 144,000.00 |
| Mar 31, 2022 | 140,000.00 |
| Dec 31, 2021 | 71,000.00 |
| Sep 30, 2021 | 11,000.00 |